The rationale: failure to demonstrate high levels of caspase 3 (an end protein in the apoptotic process) in all OLP patients [11], weak TUNEL test positivity [11], as well as increased expression of proliferative markers (PCNA, Ki-67), reported by some authors [12–16]. This evidence concerns the gene CASP3 and oral lichen planus.